Breaking News

Alkermes Completes $91M Sale of Athlone Facility to Novo Nordisk

Companies entered into subcontracting arrangements to continue certain development and manufacturing activities.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Alkermes plc has completed the sale of its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. In connection with the closing of the transaction, Alkermes will receive a one-time cash payment for the facility and certain related assets of approximately $91 million.   “With the completion of the sale of the development and manufacturing facility in Athlone, Ireland, we delivered on a significant element of our multi-year program to drive operational efficiency and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters